Dynasil Corp. of America :DYSL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 26, 2017

Dynasil Corp. of America reports financial results for the quarter ended March 31, 2017.

We analyze the earnings along side the following peers of Dynasil Corp. of America – LightPath Technologies, Inc. Class A, II-VI Incorporated, Research Frontiers Incorporated, Corning Inc and Thermo Fisher Scientific Inc. (LPTH-US, IIVI-US, REFR-US, GLW-US and TMO-US) that have also reported for this period.

Highlights

  • Summary numbers: Revenues of USD 10.09 million, Net Earnings of USD -0.06 million.
  • Gross margins widened from 36.10% to 37.56% compared to the same period last year, operating (EBITDA) margins now 3.07% from 3.26%.
  • Year-on-year change in operating cash flow of 339.83% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
  • Narrowing of operating margins contributed to decline in earnings.

The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth:

2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31
Relevant Numbers (Quarterly)
Revenues (mil) 10.09 9.14 10.54 10.41 11.3
Revenue Growth (%YOY) -10.72 -18.4 -2.3 1.63 14.16
Earnings (mil) -0.06 2.81 0.36 0.26 -0.03
Earnings Growth (%YOY) -77.42 2549.06 4350 -33.51 68.69
Net Margin (%) -0.55 30.71 3.38 2.48 -0.27
EPS -0 0.17 0.02 0.02 -0
Return on Equity (%) -1.08 64.08 9.74 7.11 -0.86
Return on Assets (%) -0.78 40.58 5.39 3.94 -0.47

Access our Ratings and Scores for Dynasil Corp. of America

Market Share Versus Profits

Revenues History
Earnings History

DYSL-US‘s change in revenue this period compared to the same period last year of -10.72% is almost the same as its change in earnings, and is about average among the announced results thus far in its peer group, suggesting that DYSL-US is holding onto its market share. Also, for comparison purposes, revenues changed by 10.30% and earnings by -101.96% compared to the immediate last period.

Revenues Growth Versus Earnings Growth

Quadrant label definitions. Hover to know more

Leader, Earnings Focus, Laggard, Revenues Focus

Earnings Growth Analysis

The company’s earnings declined year-on-year largely because of the increases in operating costs. Its operating margins (EBITDA margins) went from 3.26% to 3.07%. This decline in earnings would have been worse except for the fact that the company showed improvement in gross margins, from 36.10% to 37.56%. For comparison, gross margins were 38.55% and EBITDA margins 4.23% in the immediate last period.

Gross Margin Versus EBITDA Margin

Quadrant label definitions. Hover to know more

Differentiated; Low Cost, Commodity; Low Cost, Commodity; High Cost, Differentiated; High Cost

Gross Margin Trend

Companies sometimes sacrifice improvements in revenues and margins in order to extend friendlier terms to customers and vendors. Capital Cube probes for such activity by comparing the changes in gross margins with any changes in working capital. If the gross margins improved without a worsening of working capital, it is possible that the company’s performance is a result of truly delivering in the marketplace and not simply an accounting prop-up using the balance sheet.

Gross Margin History
Working Capital Days History

DYSL-US‘s gross margin improvement has not produced any big difference in its working capital. Working capital days are currently 52.81, compared to last year’s level of 12.48 days. This leads Capital Cube to conclude that the improvements in gross margins are likely from operating decisions and not trade-offs with the balance sheet.

Gross Margin Versus Working Capital Days

Quadrant label definitions. Hover to know more

Customer Financed, Cash Starved, Supplier Financed, Cash Rich

Cash Versus Earnings – Sustainable Performance?

It is important to examine a company�s cash versus earnings numbers to gauge whether its performance is sustainable.

DYSL-US‘s change in operating cash flow of 339.83% compared to the same period last year is about the same as its change in earnings this period. Additionally, this change in operating cash flow is about average among its peer group. This suggests that the company did not use accruals or reserves to manage earnings this period, and that, all else being equal, the earnings number is sustainable.

Operating Cash Flow Growth Versus Earnings Growth

Quadrant label definitions. Hover to know more

Cash Flow based Earnings, Likely Non-cash Earnings, Low Cash Flow Base, Likely Undeclared Earnings

Margins

The company’s decline in earnings has been influenced by the following factors: (1) Decline in operating margins (EBIT margins) from 0.36% to -0.03% and (2) one-time items that contributed to a decrease in pretax margins from -0.32% to -0.48%

EBIT Margin Versus PreTax Margin

Quadrant label definitions. Hover to know more

Operation driven Earnings, One-time Favorables, Low Earnings Base, One-time Unfavorables
EBIT Margin History
PreTax Margin History

Access our Ratings and Scores for Dynasil Corp. of America

Company Profile

Dynasil Corp. of America develops, manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through segments: Contract Research, Optics, Instruments and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. which performs research and development activities for government agencies. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used for baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, semiconductor/electronic devices, automotive components, spacecraft/aircraft components, advertising displays, and devices for the solar energy industry. These products are offered through four business units: Dynasil Fused Silica, Optometrics, Hilger Crystal, and Evaporated Metal Films. The Instruments segment manufactures precision instruments such as handheld lead paint analyzers, medical probes that help surgeons detect cancer tracers, thereby enabling more effective surgical procedures, and a radiation imaging camera system used in nuclear safety, radiation protection, and homeland security border and port surveillance. The Biomedical segment focuses on developing disruptive technologies for a wide spectrum of applications, including hematology, hypothermic core cooling and tissue sealants. This segment consists of single business unit, Dynasil Biomedical corp. a medical technology incubator. Dynasil Corp. of America was founded in October 20, 1960 and is headquartered in Watertown, MA.

CapitalCube does not own any shares in the stocks mentioned and focuses solely on providing unique fundamental research and analysis on approximately 50,000 stocks and ETFs globally. Try any of our analysis, screener or portfolio premium services free for 7 days. To get a quick preview of our services, check out our free quick summary analysis of DYSL-US.